Genknowme, a start-up specializing in epigenetics research, has integrated multichannel pipettes from INTEGRA Biosciences into its liquid handling workflows. These liquid handling solutions will enable the lab to provide fast epigenetic assessments that will support healthcare professionals in suggesting lifestyle changes to improve their patients’ quality of life.
Syndax enters funding agreement with Royalty Pharma for Niktimvo
Niktimvo, an anti-CSF-1R antibody, has received approval in the US for treating chronic GVHD. Credit: Andrei_R/Shutterstock. Syndax Pharmaceuticals has entered a synthetic royalty funding agreement